Anti-European white birch Bet v 1/Allergen Bet v I-A Polyclonal Antibody
Product Specifications
Background
Ocrelizumab (Ocrevus®) is an intravenously administered, humanized anti-CD20 monoclonal antibody approved for the treatment of adults with relapsing forms of multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS) . Antibodysystem Anti-Ocrelizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Ocrelizumab.
Host
Rabbit
Immunogen
E. coli - derived recombinant European white birch Bet v 1/Allergen Bet v I-A (Met1-Asn160) .
Target
Major pollen allergen Bet v 1-A, Allergen Bet v I-A, Bet v 1-A, BETVIA, BETVI, Betula pendula (European white birch) (Betula verrucosa)
Clonality
Polyclonal
Applications
ELISA, IHC, WB
Purification
Purified by antigen affinity column.
Form
Liquid
Buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Notes
For research use only.
Species
Betula pendula (European white birch) (Betula verrucosa)
Isotype
IgG
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7168529 Inquire
Rabbit anti-Escherichia coli O139:H28 (strain E24377A/ETEC) ZNTB Polyclonal Antibody
Ask
View Details 